A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis

[1]  V. Meininger,et al.  A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis , 2019, Scientific Reports.

[2]  H. Mitsumoto,et al.  [A prognostic biomarker in amyotrophic lateral sclerosis]. , 2018, Rinshō shinkeigaku Clinical neurology.

[3]  Karel G M Moons,et al.  Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model , 2018, The Lancet Neurology.

[4]  F. Salachas,et al.  Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis , 2018, Neurology.

[5]  L. Defebvre,et al.  Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis? , 2017, Antioxidants & redox signaling.

[6]  B. Stockwell,et al.  Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.

[7]  Jing Yuan,et al.  Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study , 2017, Scientific Reports.

[8]  O. Witte,et al.  Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease , 2017, Neurology.

[9]  A. Cagnin,et al.  Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease , 2017, JAMA neurology.

[10]  K. Blennow,et al.  Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[11]  G. Garçon,et al.  Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[12]  R. Bordet,et al.  Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC , 2016, Neurobiology of Disease.

[13]  P. Vourc'h,et al.  Biological follow‐up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis , 2015, European journal of neurology.

[14]  Qitao Ran,et al.  Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis* , 2015, The Journal of Biological Chemistry.

[15]  N. Pearce,et al.  Neurofilament light chain , 2015, Neurology.

[16]  D. Devos,et al.  Iron Metabolism Disturbance in a French Cohort of ALS Patients , 2014, BioMed research international.

[17]  V. Meininger,et al.  A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis , 2014, European journal of neurology.

[18]  J. Connor,et al.  Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis. , 2013, JAMA neurology.

[19]  M. Smith,et al.  Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links , 2013, Free radical research.

[20]  V. Meininger,et al.  Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis , 2012, PloS one.

[21]  C. Hervás,et al.  A Meta-Analysis Study , 2012 .

[22]  T. Hirayama,et al.  Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. , 2012, Internal medicine.

[23]  M. Bogdanov,et al.  Oxidative stress biomarkers in sporadic ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[24]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[25]  L. Defebvre,et al.  Elevated IL-6 and TNF-α levels in patients with ALS: Inflammation or hypoxia? , 2005, Neurology.

[26]  L. Defebvre,et al.  Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? , 2005, Neurology.

[27]  S. Appel,et al.  Increased lipid peroxidation in sera of ALS patients , 2004, Neurology.

[28]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[29]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.